Showing 7701-7710 of 9116 results for "".
- Kerecis Scores DoD Grant to Develop, Test New Fish-skin Wound Treatment for Soldiershttps://practicaldermatology.com/news/kerecis-scores-dod-grant-to-develop-test-new-fish-skin-wound-treatment-for-soldiers/2460561/The U.S. Department of Defense (DoD) awarded a grant of almost $600,000 to Kerecis to test the company’s fish-skin technology to better stabilize battlefield wounds and provide a bacterial barrier for them during evacuation. The grant money will be disbursed to Kerecis over
- SkinCeuticals, Aesthetics Biomedical Join Forces for Vivace Experience Featuring SkinCeuticals C E Ferulichttps://practicaldermatology.com/news/skinceuticals-aesthetics-biomedical-join-forces-for-vivace-experience-featuring-skinceuticals-c-e-ferulic/2460558/SkinCeuticals is teaming up Aesthetics Biomedical’s Vivace Fractional Micro Needle Radio Frequency Treatment to create the professional Vivace Experience featuring SkinCeuticals C E Ferulic MaryAnn Guerra, CEO & President of Aesthetics Biomedical states, "Aesth
- Vyne Therapeutics Announces Covered Status for Zilxi with Express Scriptshttps://practicaldermatology.com/news/yne-therapeutics-announces-covered-status-for-zilxi-with-express-scripts/2460557/Vyne Therapeutics Inc.’s Zilxi (minocycline) will be covered on Express Scripts' National Preferred, Flex, and Basic commercial formularies effective O
- It's a Deal: Allergan Buys Luminera Dermal-Filler Businesshttps://practicaldermatology.com/news/its-a-deal-allergan-buys-luminera-dermal-filler-business/2460556/Allergan Aesthetics, an AbbVie company, has acquired Luminera's full dermal filler portfolio and R&D pipeline. Luminera is a privately held aesthetics company based in Israel with a portfolio and pipeline of dermal filler products. "
- NRS Survey Reveals Age Gap in Rosacea Treatmenthttps://practicaldermatology.com/news/nrs-survey-reveals-age-gap-in-rosacea-treatment/2460553/Most rosacea patients are satisfied with the oral and topical prescription therapies they are using to treat this disorder, but individuals 60 and older are more likely to use older treatments, rather than newer products that may more effectively target specific signs and symptoms, finds a new Na
- Cynosure Launches FlexSure in US and Canadahttps://practicaldermatology.com/news/cynosure-launches-flexsure-device/2460552/Cynosure is launching FlexSure, the latest addition to the TempSure platform, in the US and Canada. FlexSure is a wrappable radiofrequency (RF) applicator for hands-free treatment on all patients and all skin types. With peel-and-sti
- Zilxi from Vyne Therapeutics Now Availablehttps://practicaldermatology.com/news/zilxi-from-vyne-therapeutics-now-available/2460551/Zilxi™ (minocycline) topical foam, 1.5% is now available by prescription for the treatment of inflammatory lesions of rosacea in adults. Zilxi, from Vyne Therapeutics, Inc. is the first minocycline product of any form to be approved by the FDA for use in rosacea, a diverse skin co
- FemiClear for Genital Herpes Symptoms Launcheshttps://practicaldermatology.com/news/femiclear-for-genital-herpes-symptoms-launches/2460547/FemiClear brand has released new FemiClear for Genital Herpes Symptoms to relieve the symptoms of genital herpes outbreaks. This new product, backed by both an in vitroand in vivostudy, is now available at CVS stores nationwide. New
- NEA Shares Educational Resources for October's Eczema Awareness Monthhttps://practicaldermatology.com/news/nea-shares-educational-resources-for-octobers-eczema-awareness-month/2460545/The National Eczema Association (NEA) is offering a robust series of virtual educational programs, patient/caregiver support experiences, community engagement activities and free resources throughout October's Eczema Awareness Month This year's month-long stakeholder engagement
- Industry Responds to COVID-19: BTL Gives Backhttps://practicaldermatology.com/news/coping-with-covid-19-btl-gives-back/2460542/BTL is revamping several of their manufacturing facilities to provide face masks and ventilators to the medical community. As of September 2020, BTL's European manufacturing facilities have been producing ventilators and masks including